Angelique A. C. Lemckert

3.9k total citations
33 papers, 2.7k citations indexed

About

Angelique A. C. Lemckert is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Angelique A. C. Lemckert has authored 33 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 18 papers in Molecular Biology and 17 papers in Infectious Diseases. Recurrent topics in Angelique A. C. Lemckert's work include Virus-based gene therapy research (25 papers), CAR-T cell therapy research (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Angelique A. C. Lemckert is often cited by papers focused on Virus-based gene therapy research (25 papers), CAR-T cell therapy research (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Angelique A. C. Lemckert collaborates with scholars based in Netherlands, United States and United Kingdom. Angelique A. C. Lemckert's co-authors include Menzo Havenga, Jaap Goudsmit, Dan H. Barouch, Ronald Vogels, Lennart Holterman, Bonnie A. Ewald, Diana M. Lynch, Peter Abbink, Angela Carville and Keith G. Mansfield and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Angelique A. C. Lemckert

33 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angelique A. C. Lemckert Netherlands	23	1.9k	1.3k	880	796	516	33	2.7k
Ronald Vogels Netherlands	28	1.8k 0.9×	1.8k 1.3×	1000 1.1×	714 0.9×	735 1.4×	40	3.7k
Jerome Custers Netherlands	19	1.3k 0.7×	1.1k 0.8×	757 0.9×	539 0.7×	278 0.5×	33	2.2k
Zhiquan Xiang United States	27	1.2k 0.6×	836 0.6×	876 1.0×	388 0.5×	902 1.7×	49	2.5k
Lennart Holterman Netherlands	17	1.1k 0.6×	759 0.6×	585 0.7×	410 0.5×	375 0.7×	27	1.7k
Diana M. Lynch United States	16	1.1k 0.6×	890 0.7×	645 0.7×	394 0.5×	772 1.5×	16	2.2k
Jason G. Gall United States	22	1.0k 0.5×	736 0.6×	527 0.6×	393 0.5×	382 0.7×	42	1.6k
Gerald W. Both Australia	27	1.1k 0.6×	1.1k 0.8×	565 0.6×	219 0.3×	336 0.7×	57	2.1k
Saw See Hong France	27	1.0k 0.5×	1.1k 0.8×	554 0.6×	481 0.6×	207 0.4×	46	1.9k
Peter Abbink United States	25	1.0k 0.5×	876 0.7×	1.0k 1.1×	373 0.5×	850 1.6×	43	2.7k
Darci A. Gorgone United States	25	1.1k 0.6×	1.1k 0.8×	1.0k 1.1×	502 0.6×	1.7k 3.2×	30	3.4k

Countries citing papers authored by Angelique A. C. Lemckert

Since Specialization

Citations

This map shows the geographic impact of Angelique A. C. Lemckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelique A. C. Lemckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelique A. C. Lemckert more than expected).

Fields of papers citing papers by Angelique A. C. Lemckert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelique A. C. Lemckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelique A. C. Lemckert. The network helps show where Angelique A. C. Lemckert may publish in the future.

Co-authorship network of co-authors of Angelique A. C. Lemckert

This figure shows the co-authorship network connecting the top 25 collaborators of Angelique A. C. Lemckert. A scholar is included among the top collaborators of Angelique A. C. Lemckert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelique A. C. Lemckert. Angelique A. C. Lemckert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lemckert, Angelique A. C., Gert Gillissen, Julie E. Bines, et al.. (2021). Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine. Vaccine. 39(15). 2048–2059. 7 indexed citations

2.

Ballmann, Mónika Z., Győző L. Kaján, Abdelaziz Beqqali, et al.. (2021). Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development. Journal of Virology. 95(22). e0038721–e0038721. 8 indexed citations

3.

Karpilow, Jon, Fija M. Lagerwerf, Menzo Havenga, et al.. (2018). Enhancing viral vaccine production using engineered knockout vero cell lines – A second look. Vaccine. 36(16). 2093–2103. 14 indexed citations

4.

Alonso-Padilla, Julio, Tibor Papp, Győző L. Kaján, et al.. (2015). Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs. Molecular Therapy. 24(1). 6–16. 78 indexed citations

5.

Vellinga, Jort, Agnieszka Lipiec, Dragomira Majhen, et al.. (2014). Challenges in Manufacturing Adenoviral Vectors for Global Vaccine Product Deployment. Human Gene Therapy. 25(4). 318–327. 63 indexed citations

6.

Radošević, Katarina, Ariane Rodrı́guez, Angelique A. C. Lemckert, et al.. (2011). The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert (vol 17, pg 1687, 2010). Clinical and Vaccine Immunology. 18(2). 1 indexed citations

7.

Radošević, Katarina, Ariane Rodrı́guez, Angelique A. C. Lemckert, et al.. (2011). The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert. Clinical and Vaccine Immunology. 18(2). 353–353. 1 indexed citations

8.

Radošević, Katarina, Ariane Rodrı́guez, Angelique A. C. Lemckert, et al.. (2010). The Th1 Immune Response toPlasmodium falciparumCircumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert. Clinical and Vaccine Immunology. 17(11). 1687–1694. 44 indexed citations

9.

Liu, Jinyan, Bonnie A. Ewald, Diana M. Lynch, et al.. (2008). Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys. Journal of Virology. 82(10). 4844–4852. 90 indexed citations

10.

Thorner, Anna R., Angelique A. C. Lemckert, Jaap Goudsmit, et al.. (2006). Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity. Journal of Virology. 80(24). 12009–12016. 48 indexed citations

11.

Roberts, D.M., Menzo Havenga, Peter Abbink, et al.. (2006). Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature. 441(7090). 239–243. 391 indexed citations

12.

Lemckert, Angelique A. C., Jos Grimbergen, Lennart Holterman, et al.. (2006). Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity. Journal of General Virology. 87(10). 2891–2899. 70 indexed citations

13.

Lemckert, Angelique A. C., Jaap Goudsmit, & Dan H. Barouch. (2004). Challenges in the Search for an HIV Vaccine. European Journal of Epidemiology. 19(6). 513–516. 14 indexed citations

14.

Eleveld-Trancikova, Dagmar, Vassilis Triantis, Véronique Moulin, et al.. (2004). The dendritic cell-derived protein DC-STAMP is highly conserved and localizes to the endoplasmic reticulum. Journal of Leukocyte Biology. 77(3). 337–343. 30 indexed citations

15.

Lefesvre, Pierre, et al.. (2003). Genetic heterogeneity in response to adenovirus gene therapy. BMC Molecular Biology. 4(1). 4–4. 13 indexed citations

16.

Réa, Delphine, Menzo Havenga, Roger P.M. Sutmuller, et al.. (2001). Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells. The Journal of Immunology. 166(8). 5236–5244. 130 indexed citations

17.

Goossens, Paulien H., Menzo Havenga, Elsbet Pieterman, et al.. (2001). Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis & Rheumatism. 44(3). 570–577. 37 indexed citations

18.

Havenga, Menzo, Angelique A. C. Lemckert, Jos Grimbergen, et al.. (2001). Improved Adenovirus Vectors for Infection of Cardiovascular Tissues. Journal of Virology. 75(7). 3335–3342. 109 indexed citations

19.

Knaän‐Shanzer, Shoshan, Ietje van der Velde, Menzo Havenga, et al.. (2001). Highly Efficient Targeted Transduction of Undifferentiated Human Hematopoietic Cells by Adenoviral Vectors Displaying Fiber Knobs of Subgroup B. Human Gene Therapy. 12(16). 1989–2005. 61 indexed citations

20.

Goossens, Paulien H., Menzo Havenga, Elsbet Pieterman, et al.. (2001). Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis & Rheumatism. 44(3). 570–577. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact